GSK Sues Pfizer for Alleged RSV Vaccine Patent Infringement

GlaxoSmithKline filed a lawsuit against Pfizer on Wednesday for allegedly infringing on four patents related to the antigen used in GSK’s Arexvy respiratory syncytial virus shot, according to multiple media reports.